Concurrent Session: ABCs of Point of Care Manufacturing of IEC
Saturday, September 9, 2023 03:15 PM - 04:15 PM
335 AB
Chair
Olive J. Sturtevant, MHP, MT(ASCP)SBB,SLS, CQA(ASQ), Dana Farber Cancer Institute, USA
Speakers
Don Siegel, MD, PhD, University of Pennsylvania, USA – Institutional Infrastructure Considerations for POC Manufacturing of IEC
Tim Wiltshire, PhD, Mayo Clinic Rochester, USA – IEC testing strategies for POC manufacturing
Sarah Nikiforow, MD, PhD, Dana-Farber Cancer Institute, USA – What is that? – vagaries encountered at each step of POC manufacturing
Simplified presentations of key elements involved in IEC point of care manufacturing including finances, business model, regulatory, technical, staffing, etc.
Session Objectives
Olive J. Sturtevant, MHP, MT(ASCP)SBB,SLS, CQA(ASQ), Dana Farber Cancer Institute, USA
Speakers
Don Siegel, MD, PhD, University of Pennsylvania, USA – Institutional Infrastructure Considerations for POC Manufacturing of IEC
Tim Wiltshire, PhD, Mayo Clinic Rochester, USA – IEC testing strategies for POC manufacturing
Sarah Nikiforow, MD, PhD, Dana-Farber Cancer Institute, USA – What is that? – vagaries encountered at each step of POC manufacturing
Simplified presentations of key elements involved in IEC point of care manufacturing including finances, business model, regulatory, technical, staffing, etc.
Session Objectives
- Discuss the scientific and clinical infrastructure needed to support a POC IEC program.
- Provide an overview on the types of product testing needed for both in-process and release testing for POC IEC manufacturing.
- Explore potential variation in starting material, manufacturing events and final product analyses that POC manufacturers should be prepared to manage
Olive J Sturtevant MHP, MT(ASCP)SBB,SLS, CQA(ASQ)
Senior Administrative Director of Connell & O'Reilly Families, Cell Manipulation Core Facility
Dana Farber Cancer Institute
Chair
Senior Administrative Director of Connell & O'Reilly Families, Cell Manipulation Core Facility
Dana Farber Cancer Institute
Chair
Sarah Nikiforow MD, PhD
Asst Professor, Stem Cell Transplantation Program, Asst. Medical Director, Cell Manipulation Core Facility, Technical Director, Immune Effector Program
Dana-Farber Cancer Institute
Speaker
Asst Professor, Stem Cell Transplantation Program, Asst. Medical Director, Cell Manipulation Core Facility, Technical Director, Immune Effector Program
Dana-Farber Cancer Institute
Speaker
